文献速递脊柱外科

颈椎间盘置换术20年临床结局:前瞻性随机对照试验

20-year Clinical Outcomes of Cervical Disk Arthroplasty: A Prospective, Randomized, Controlled Trial.
PubMed 文献 · Spine (Phila Pa 1976) · 2023-08-30

47例单节段颈椎神经根病患者随机接受BRYAN颈椎间盘置换(CDA)或前路颈椎间盘切除融合(ACDF),20年随访率91.3%。两组NDI、VAS臂痛和VAS颈痛均较术前显著改善,CDA组再手术率10.0%低于ACDF组41.7%(P=0.039),但20年时两组NDI、VAS臂痛和VAS颈痛评分无显著差异。

要点

  • 20年随访时CDA与ACDF的NDI、VAS臂痛和VAS颈痛评分均无显著差异。
  • CDA组再手术率10.0%低于ACDF组41.7%(P=0.039)。
  • ACDF组20年症状性不融合率为4.2%,CDA组无置换装置失败需再手术。

核心结论

  • CDA和ACDF在治疗颈椎神经根病方面均有效,20年时NDI、VAS颈痛和VAS臂痛均持续改善。
  • CDA的再手术率低于ACDF。
  • CDA组无置换装置失败需在索引节段再手术。
  • ACDF组20年症状性不融合率为4.2%。
  • 尽管CDA组再手术率高于ACDF组,但20年NDI、VAS颈痛和VAS臂痛评分无差异。

研究设计与样本

  • 前瞻性随机对照试验,47例单节段颈椎神经根病患者随机分配至BRYAN CDA或ACDF,作为美国食品药品监督管理局研究性器械豁免试验的一部分。
  • 20年时分析患者报告结局,包括颈部和臂部疼痛视觉模拟量表(VAS)、颈部功能障碍指数(NDI)和再手术率。

主要发现

  • 随访率91.3%。
  • 两组20年时NDI、VAS臂痛和VAS颈痛评分均显著优于术前。
  • CDA组 vs ACDF组20年NDI平均评分11.1(SD 14.1) vs 19.9(SD 17.2),P=0.087。
  • CDA组 vs ACDF组20年VAS臂痛平均评分0.9(SD 2.4) vs 2.3(SD 2.8),P=0.095。
  • CDA组 vs ACDF组20年VAS颈痛平均评分1.2(SD 2.5) vs 2.9(SD 3.3),P=0.073。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Prospective, randomized, controlled trial. OBJECTIVE: To compare clinical outcomes of anterior cervical discectomy and fusion (ACDF) and cervical disk arthroplasty (CDA) at 20 years. SUMMARY OF BACKGROUND DATA: Concern for adjacent-level disease after ACDF prompted the development of CDA. MATERIALS AND METHODS: Forty-seven patients with single-level cervical radiculopathy were randomized to either BRYAN CDA or ACDF for a Food and Drug Administration Investigational Device Exemption trial. At 20 years, patient-reported outcomes, including visual analog scales (VAS) for neck and arm pain, neck disability index (NDI), and reoperation rates, were analyzed. RESULTS: Follow-up rate was 91.3%. Both groups showed significantly better NDI, VAS arm pain, and VAS neck pain scores at 20 years versus preoperative scores. Comparing CDA versus ACDF, there was no difference at 20 years in mean scores for NDI [11.1 (SD 14.1) vs. 19.9 (SD 17.2), P =0.087], mean VAS arm pain [0.9 (SD 2.4) vs. 2.3 (SD 2.8), P =0.095], or mean VAS neck pain [1.2 (SD 2.5) vs. 2.9 (3.3), P =0.073]. There was a significant difference between CDA versus ACDF groups in the change in VAS neck pain score between 10 and 20 years [respectively, -0.4 (SD 2.5) vs. 1.5 (SD 2.5), P =0.030]. Reoperations were reported in 41.7% of ACDF patients and 10.0% of CDA patients ( P =0.039). CONCLUSIONS: Both CDA and ACDF are effective in treating cervical radiculopathy with sustained improvement in NDI, VAS neck and VAS arm pain at 20 years. CDA demonstrates lower reoperation rates than ACDF. There were no failures of the arthroplasty device requiring reoperation at the index level. The symptomatic nonunion rate of ACDF was 4.2% at 20 years. Despite a higher reoperation rate in the CDA group versus ACDF group, there was no difference in the 20-year NDI, VAS Neck, and VAS arm pain scores.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Sasso WR, Ye J, Foley DP, et al. 20-year Clinical Outcomes of Cervical Disk Arthroplasty: A Prospective, Randomized, Controlled Trial. Spine (Phila Pa 1976). 2023. PMID: 37644726. doi:10.1097/BRS.0000000000004811

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。